Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: Objective measurements

Journal of Clinical Oncology

Volumn 26, Issue 32, 2008, Pages 5213-5219

  McLaughlin, Sarah A ^a   Wright, Mary J ^a   Morris, Katherine T ^a   Giron, Gladys L ^a   Sampson, Michelle R ^a   Brockway, Julia P ^a   Hurley, Karen E ^a   Riedel, Elyn R ^a   Van Zee, Kimberly J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BODY MASS; BODY WEIGHT; BREAST CANCER; FEMALE; HUMAN; INFECTION; INJURY; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ARM; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHEDEMA; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 55949125908     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.3725     Document Type: Article

References (23)

1. Petrek JA, Senie RT, Peters M, et al: Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 92:1368-1377, 2001
2. Leidenius M, Leivonen M, Vironen J, et al: The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 92:23-31, 2005
3. Langer I, Guller U, Berclaz G, et al: Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: A prospective Swiss multicenter study on 659 patients. Ann Surg 245: 452-461, 2007
4. Cody HS 3rd, Borgen PI: State-of-the-art approaches to sentinel node biopsy for breast cancer: Study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg Oncol 8:85-91, 1999
5. Schrenk P, Rieger R, Shamiyeh A, et al: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608-614, 2000
6. Burak WE, Hollenbeck ST, Zervos EE, et al: Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183:23-27, 2002
7. Haid A, Koberle-Wuhrer R, Knauer M, et al: Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: A comparative evaluation. Breast Cancer Res Treat 73:31-36, 2002
8. Haid A, Kuehn T, Konstantiniuk P, et al: Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol 28:705-710, 2002
9. Golshan M, Martin WJ, Dowlatshahi K: Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg 69:209-211, 2003
10. Veronesi U, Paganelli G, Viale G, et al: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546-553, 2003
11. Rietman JS, Dijkstra PU, Geertzen JH, et al: Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 11:1018-1024, 2004
12. Purushotham AD, Upponi S, Klevesath MB, et al: Morbidity after sentinel lymph node biopsy in primary breast cancer: Results from a randomized controlled trial. J Clin Oncol 23:4312-4321, 2005
13. Rönkä R, von Smitten K, Tasmuth T, et al: One-year morbidity after sentinel node biopsy and breast surgery. Breast 14:28-36, 2005
14. Mansel RE, Fallowfield L, Kissin M, et al: Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. J Natl Cancer Inst 98:599-609, 2006
15. Rietman JS, Geertzen JH, Hoekstra HJ, et al: Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol 32:148-152, 2006
16. Wilke LG, McCall LM, Posther KE, et al: Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial. Ann Surg Oncol 13:491-500, 2006
17. Lucci A, McCall LM, Beitsch PD, et al: Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657-3663, 2007
18. Kissin MW, Querci della Rovere G, Easton D, et al: Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73:580-584, 1986
19. Sener SF, Winchester DJ, Martz CH, et al: Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92:748-752, 2001
20. Blanchard DK, Donohue JH, Reynolds C, et al: Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138:482-487, 2003; discussion 487-488
21. Werner RS, McCormick B, Petrek J, et al: Arm edema in conservatively managed breast cancer: Obesity is a major predictive factor. Radiology 180: 177-184, 1991
22. Baron RH, Fey JV, Borgen PI, et al: Eighteen sensations after breast cancer surgery: A 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Ann Surg Oncol 14: 1653-1661, 2007
23. McLaughlin S, Wright M, Morris K, et al: Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: Patient perceptions and precautionary behaviors. J Clin Oncol doi:10.1200/ JCO.2008.16.3766